Cargando…
Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory Drugs
Recent advances in immunotherapy have revolutionized cancer therapy. Immunotherapies can engage the adaptive and innate arms of the immune system. Therapeutics targeting immune checkpoint inhibitors (i.e., CTLA-4; PD-1, and PD-L1) have shown efficacy for subsets of cancer patients by unleashing an a...
Autores principales: | Hingorani, Dina V., Camargo, Maria F., Quraishi, Maryam A., Adams, Stephen R., Advani, Sunil J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000974/ https://www.ncbi.nlm.nih.gov/pubmed/33801967 http://dx.doi.org/10.3390/pharmaceutics13030365 |
Ejemplares similares
-
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
por: Hingorani, Dina V., et al.
Publicado: (2022) -
Tumor-Penetrating Peptides
por: Teesalu, Tambet, et al.
Publicado: (2013) -
Multiple Immune-Modulatory Functions Of Cathelicidin Host Defense Peptides
por: Choi, Ka-Yee (Grace), et al.
Publicado: (2012) -
Selective Moonlighting Cell-Penetrating Peptides
por: Morán-Torres, Rafael, et al.
Publicado: (2021) -
Endocytic Trafficking of Nanoparticles Delivered by Cell-penetrating Peptides Comprised of Nona-arginine and a Penetration Accelerating Sequence
por: Liu, Betty R., et al.
Publicado: (2013)